Company / Return on Assets (ROA)
Viking Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-50.2%
FY2025
5-year range
-50.2% / -12.1%
FY2021-FY2025
Trend
-314.9%
vs FY2024
Sector context
#175 of 213
Health Care
What the data says
Return on Assets (ROA) changed -315% YoY in FY2025, a notable deviation from the 9-year average annual change of -35%.
Based on SEC 10-K filings.
-50.2% in FY2025 with a 5-year CAGR of -40.2%.
Declined from -14.9% to -50.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -17.6pp
- 5-Year Change
- -40.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 213This company -50.2% Sector average -24.1%
▼
-108.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 314.9% year-over-year.
- Currently 26.1pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -50.2% | -314.9% |
| FY2024 | -12.1% | +18.8% |
| FY2023 | -14.9% | +54.3% |
| FY2022 | -32.6% | -74.0% |
| FY2021 | -18.8% | -86.6% |
| FY2020 | -10.1% | -29.5% |
| FY2019 | -7.8% | -14.0% |
| FY2018 | -6.8% | +92.7% |
| FY2017 | -93.0% | +42.2% |
| FY2016 | -161.0% | -13.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026